Literature DB >> 11282041

Childhood Migraine Headache Syndromes.

Arthur Prensky1.   

Abstract

The treatment of migraine headache in children depends on the following: a) defining the underlying cause; b) the frequency of the attacks; and c) the severity of the disability produced by the pain. Any medication taken to relieve pain is most effective if taken at maximum dose at the onset of the headache. The dose should be the maximum recommended by weight or age. Triptans are also more effective if used early. Over-the-counter (OTC) analgesics are often effective in relieving pediatric headache and should be tried before prescription drug therapy is attempted. The more frequent a child's headaches are, the greater the danger that repeated doses of pain medications, including those purchased OTC, will lead to a chronic headache syndrome as the medication is reduced. Recurrent severe headaches, occurring more than once a week and resulting in interruption of normal activities or poor concentration, need to be treated with prophylactic medications taken daily so that the number of headaches can be reduced. Amitriptyline, propanolol, and periactin are the most frequently used drugs to block headaches, but valproate, verapamil, or other calcium channel blockers and other antidepressants are also useful. Biofeedback, relaxation, or cognitive therapies can also reduce headache frequency in children with both migraine and tension headaches. Headaches that are intractable to oral medication for the acute relief of pain may respond more rapidly to an efficiently absorbed drug administered by nasal spray or subcutaneously. The initial dose of an injectable drug should be given in a situation where a physician is immediately available. Recurrent headaches that have occurred over more than 6 months and that are associated with a normal neurologic examination are almost never caused by an intracranial lesion. Routine CT and MRI scans or an electroencephalogram (EEG) are generally unnecessary for these patients because these scans are rarely of value in these patients unless there is a history of another neurologic disorder or the headaches are focal, relentless, and worsening over time.

Entities:  

Year:  2001        PMID: 11282041     DOI: 10.1007/s11940-001-0007-8

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  33 in total

1.  Therapeutic jaw exercises and interocclusal appliance therapy. A comparison between two common treatments of temporomandibular disorders.

Authors:  T Magnusson; M Syrén
Journal:  Swed Dent J       Date:  1999

2.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

3.  Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine.

Authors:  Z Walker; R W Walker; M M Robertson; S Stansfeld
Journal:  Headache       Date:  1998 Jul-Aug       Impact factor: 5.887

4.  Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects.

Authors:  J R Couch; D K Ziegler; R Hassanein
Journal:  Neurology       Date:  1976-02       Impact factor: 9.910

5.  Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?

Authors:  M L Hämäläinen; K Hoppu; P Santavuori
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

6.  Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice.

Authors:  S L Linder
Journal:  Headache       Date:  1996 Jul-Aug       Impact factor: 5.887

7.  Change mechanisms associated with combined relaxation/EMG biofeedback training for chronic tension headache.

Authors:  L A Rokicki; K A Holroyd; C R France; G L Lipchik; J L France; S A Kvaal
Journal:  Appl Psychophysiol Biofeedback       Date:  1997-03

8.  Effectiveness of amitriptyline in the prophylactic management of childhood headaches.

Authors:  A D Hershey; S W Powers; A L Bentti; T J Degrauw
Journal:  Headache       Date:  2000 Jul-Aug       Impact factor: 5.887

9.  Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE.

Authors:  S D Silberstein; J R Silberstein
Journal:  Headache       Date:  1992-10       Impact factor: 5.887

10.  Sinus headaches reconsidered: referred cephalgia of rhinologic origin masquerading as refractory primary headaches.

Authors:  D M Clerico
Journal:  Headache       Date:  1995-04       Impact factor: 5.887

View more
  1 in total

1.  Comparing Zonisamide With Sodium Valproate in the Management of Migraine Headaches: Double-Blind Randomized Clinical Trial of Efficacy and Safety.

Authors:  Farhad Assarzadegan; Hanif Tabesh; Seyed-Mostafa Hosseini-Zijoud; Andrew David Beale; Arya Shoghli; Mahmood Ghafoori Yazdi; Behnam Mansouri; Omid Hesami; Nahid Beladi Moghadam; Hosein Delavar Kasmaei
Journal:  Iran Red Crescent Med J       Date:  2016-04-30       Impact factor: 0.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.